Publications by authors named "Azra Mujic-Delic"

Claim this Profile
H
Human cytomegalovirus encoded chemokine receptor US28 activates the HIF-1α/PKM2 axis in glioblastoma cells.
Raymond H de Wit, Azra Mujić-Delić, Jeffrey R van Senten, Alberto Fraile-Ramos, Marco Siderius

Oncotarget· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GPCR-targeting nanobodies: attractive research tools, diagnostics, and therapeutics.
Azra Mujić-Delić, Raymond H de Wit, Folkert Verkaar, Martine J Smit

Trends Pharmacol Sci· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Llama-derived single variable domains (nanobodies) directed against chemokine receptor CXCR7 reduce head and neck cancer cell growth in vivo.
David Maussang, Azra Mujić-Delić, Francis J Descamps, Catelijne Stortelers, Peter Vanlandschoot

J Biol Chem· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutralizing nanobodies targeting diverse chemokines effectively inhibit chemokine function.
Christophe Blanchetot, Dennis Verzijl, Azra Mujić-Delić, Leontien Bosch, Louise Rem

J Biol Chem· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis, modeling and functional activity of substituted styrene-amides as small-molecule CXCR7 agonists.
Maikel Wijtmans, David Maussang, Francesco Sirci, Danny J Scholten, Meritxell Canals

Eur J Med Chem· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis